Characterization of the degradation mechanisms of lysine-derived aliphatic poly(ester urethane) scaffolds
Source abstract
Abstract
Characterization of the degradation mechanism of polymeric scaffolds and delivery systems for regenerative medicine is essential to assess their clinical applicability. Key performance criteria include induction of a minimal, transient inflammatory response and controlled degradation to soluble non-cytotoxic breakdown products that are cleared from the body by physiological processes. Scaffolds fabricated from biodegradable poly(ester urethane)s (PEURs) undergo controlled degradation to non-cytotoxic breakdown products and support the ingrowth of new tissue in preclinical models of tissue regeneration. While previous studies have shown that PEUR scaffolds prepared from lysine-derived polyisocyanates degrade faster under in vivo compared to in vitro conditions, the degradation mechanism is not well understood. In this study, we have shown that PEUR scaffolds prepared from lysine triisocyanate (LTI) or a trimer of hexamethylene diisocyanate (HDIt) undergo hydrolytic, esterolytic, and oxidative degradation. Hydrolysis of ester bonds to yield α-hydroxy acids is the dominant mechanism in buffer, and esterolytic media modestly increase the degradation rate. While HDIt scaffolds show a modest (<20%) increase in degradation rate in oxidative medium, LTI scaffolds degrade six times faster in oxidative medium. Furthermore, the in vitro rate of degradation of LTI scaffolds in oxidative medium approximates the in vivo rate in rat excisional wounds, and histological sections show macrophages expressing myeloperoxidase at the material surface. While recent preclinical studies have underscored the potential of injectable PEUR scaffolds and delivery systems for tissue regeneration, this promising class of biomaterials has a limited regulatory history. Elucidation of the macrophage-mediated oxidative mechanism by which LTI scaffolds degrade in vivo provides key insights into the ultimate fate of these materials when injected into the body.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Wound Healing and Treatments · Electrospun Nanofibers in Biomedical Applications · biodegradable polymer synthesis and properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Controlled release of bioactive agents from lactide/glycolide polymers
2. Bioerodible polyanhydrides for controlled drug delivery10.1016/0142-9612(83)90054-6 ↗
3. Tyrosine-derived polycarbonates: backbone-modified “pseudo”-poly (amino acids) designed for biomedical applications10.1002/bip.360320418 ↗
4. Controlled release using a new bioerodible polyphosphazene matrix system10.1002/jbm.820211006 ↗
5. In vitro degradation of a poly(propylene fumarate)-based composite material10.1016/0142-9612(96)00008-7 ↗
6. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
7. Design and synthesis of biodegradable poly(ester-urethane) elastomer networks composed of non-toxic building blocks10.1002/marc.1988.030090814 ↗
8. Hydrolyzable poly(ester-urethane) networks from L-lysine diisocyanate and d, l-lactide/e-caprolactone homo- and copolyester triols10.1002/pola.1994.080321216 ↗
9. Development of degradable polyesterurethanes for medical applications: in vitro and in vivo evaluations10.1002/(SICI)1097-4636(199707)36:1<65::AID-JBM8>3.0.CO;2-J ↗
10. In vivo performance of a new biodegradable polyester urethane system used a nerve guidance channel10.1016/S0142-9612(98)00122-7 ↗
11. Identification of biodegradation products formed by l-phenylalanine based segmented polyurethaneureas10.1163/156856202320269166 ↗
12. A new peptide-based urethane polymer: synthesis, biodegradation, and potential to support cell growth in vitro10.1016/S0142-9612(00)00005-3 ↗
13. Synthesis, biodegradability, and biocompatibility of lysine diisocyanate-glucose polymers10.1089/10763270260424132 ↗
14. Synthesis and biocompatibility of polyurethane foam scaffolds from lysine diisocyanate and polyester polyols10.1089/ten.2006.12.1247 ↗
15. Synthesis, in vitro biocompatibility and biodegradation, and mechanical properties of two-component polyurethane scaffolds: effects of water and polyol composition10.1089/ten.2006.0395 ↗
16. An elastic, biodegradable cardiac patch induces contractile smooth muscle and improves cardiac remodeling and function in subacute myocardial infarction10.1016/j.jacc.2007.02.050 ↗
17. The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds10.1016/j.biomaterials.2009.03.008 ↗
18. Studies of poly(urethane urea) bands for ACL reconstruction10.1023/A:1014380332762 ↗
19. The effects of controlled release of BMP-2 from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femoral plug model10.1016/j.biomaterials.2009.08.038 ↗
20. Biodegradable injectable polyurethanes: synthesis and evaluation for orthopaedic applications10.1016/j.biomaterials.2008.06.021 ↗
21. Regeneration of bicortical defects in the iliac crest of estrogen-deficient sheep, using new biodegradable polyurethane bone graft substitutes10.1002/jbm.a.30669 ↗
22. Lelah · 1987
23. Biodegradation of a poly(ester)urea-urethane by cholesterol esterase: isolation and identification of principal biodegradation products10.1002/(SICI)1097-4636(19970905)36:3<407::AID-JBM16>3.0.CO;2-A ↗
24. Enzyme-induced biodegradation of polycarbonate polyurethanes: dependence on hard-segment concentration10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B ↗
25. Human macrophage-mediated biodegradation of polyurethanes: assessment of candidate enzyme activities10.1016/S0142-9612(02)00137-0 ↗
26. Understanding the biodegradation of polyurethanes: from classical implants to tissue engineering materials10.1016/j.biomaterials.2005.05.079 ↗
27. The interaction between hydrolytic and oxidative pathways in macrophage-mediated polyurethane degradation10.1002/jbm.a.31263 ↗
28. Some observations on the role of cellular enzymes in polymer degradation
29. Oxidative mechanisms of poly(carbonate urethane) and poly(ether urethane) biodegradation: in vivo and in vitro correlations10.1002/jbm.a.30067 ↗
30. Foreign-body giant cells and polyurethane biostability: in vivo correlation of cell adhesion and surface cracking10.1002/jbm.820250205 ↗
31. Synthesis, characterization, and cytocompatibility of polyurethaneurea elastomers with designed elastase sensitivity10.1021/bm0503322 ↗
32. Injectable biodegradable polyurethane scaffolds with release of platelet-derived growth factor for tissue repair and regeneration10.1007/s11095-008-9618-z ↗
33. Adhikari R, Gunatillake PA, inventors. Biodegradable polyurethane/urea compositions Patent No. WO 2004/009227 A2, 2004.
34. Rapidly degraded terpolymers of d, l-lactide, glycolide, and ɛ-caprolactone with increased hydrophilicity by copolymerization with polyethers10.1002/jbm.820241011 ↗
35. The biodegradation of poly(urethane)s by the esterolytic activity of serine proteases and oxidative enzyme systems10.1163/156856299X00595 ↗
36. Role of oxygen in biodegradation of poly(etherurethane urea) elastomers10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7 ↗
37. Model systems to assess the destructive potential of human neutrophils and monocyte-derived macrophages during the acute and chronic phases of inflammation10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8 ↗
38. ASTM-International · 2007
39. ASTM-International · 2007
40. Macrophage-mediated biodegradation of poly(d, l-lactide-co-glycolide) in vitro10.1002/jbm.a.30853 ↗
41. Cyclic strain and motion control produce opposite oxidative responses in two human endothelial cell types10.1152/ajpcell.00585.2006 ↗
42. Synthetic polymeric substrates as potent pro-oxidant versus anti-oxidant regulators of cytoskeletal remodeling and cell apoptosis10.1002/jcp.21629 ↗
43. Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications10.1016/j.biomaterials.2004.10.018 ↗
44. Biodegradable porous polyurethane scaffolds for tissue repair and regeneration10.1002/jbm.a.30708 ↗
45. Hydrolytic degradation of tyrosine-derived polycarbonates, a class of new biomaterials. Part I: study of model compounds10.1016/S0142-9612(00)00104-6 ↗
46. Synthesis, mechanical properties, biocompatibility, and biodegradation of polyurethane networks from lysine polyisocyanates10.1016/j.biomaterials.2007.12.046 ↗
47. Sclerotherapy for simple cysts with use of ethanolamine oleate: preliminary experience10.1007/s00270-004-0277-0 ↗
48. Phosphorylation of ethanolamine in catabolism: biodegradative adenosine triphosphate ethanolamine phosphotransferase and related enzymes in bacteria10.1042/bst0020133 ↗
49. Enzymatic degradation of poly(ether urethane) and poly(carbonate urethane) by cholesterol esterase10.1016/j.biomaterials.2006.03.012 ↗
50. A review on macrophage responses to biomaterials10.1088/1748-6041/1/1/R01 ↗
51. Biodegradation of polycarbonate-based polyurethanes by the human monocyte-derived macrophage and U937 cell systems10.1002/jbm.10286 ↗
52. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds10.1089/ten.tea.2008.0419 ↗
53. Macrophages form circular zones of very close apposition to lgG-Coated surfaces10.1002/cm.970150408 ↗
54. TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium
55. The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes10.1111/j.1600-065X.2007.00513.x ↗
56. Nitric oxide: a key regulator of myeloid inflammatory cell apoptosis10.1038/sj.cdd.4401152 ↗
57. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions10.1146/annurev.bi.62.070193.004053 ↗
58. Synthesis and Characterization of an injectable allograft bone/polymer composite bone void filler with tunable mechanical properties10.1089/ten.tea.2009.0672 ↗